Author: Jason Lim

CooperVision’s FDA-approved MiSight 1-day lenses have emerged as a solution to the issue of compliance with good efficacy for children. “In our 7-year trial for MiSight, we saw really impressive levels of compliance for MiSight. Because these are contact lenses, once they are put in, they stay in place, and there is less removal and replacement compared to spectacles. We’ve seen that it is common to wear 10+ hours a day and sometimes even up to 16 hours of wear during the trials,” said Shila Gupta, General Manager for Myopia Management at CooperVision.